期刊
ANTICANCER RESEARCH
卷 37, 期 1, 页码 81-85出版社
INT INST ANTICANCER RESEARCH
DOI: 10.21873/anticanres.11292
关键词
Long non-coding RNA; PANDA; p18; transcription; osteosarcoma
类别
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan [26430127]
- Takeda Science Foundation
- Grants-in-Aid for Scientific Research [26430127, 15K06994] Funding Source: KAKEN
Background: A long noncoding RNA, p21-associated ncRNA DNA damage-activated (PANDA), associates with nuclear transcription factor Y subunit alpha (NF-YA) and inhibits its binding to promoters of apoptosis-related genes, thereby repressing apoptosis in normal human fibroblasts. Here, we show that PANDA is involved in regulating proliferation in the U2OS human osteosarcoma cell line. Materials and Methods: U2OS cells were transfected with siRNAs against PANDA 72 h later and they were subjected to reverse transcription-polymerase chain reaction (RT-PCR), quantitative RT-PCR and cell-cycle analysis. Results: PANDA was highly expressed in U2OS cells, and its expression was induced by DNA damage. Silencing PANDA caused arrest at the G(1) phase of the cell cycle, leading to inhibition of cell proliferation. Quantitative RT-PCR showed that silencing PANDA increased mRNA levels of the cyclin-dependent kinase inhibitor p18, which caused G(1) phase arrest. Conclusion: These results suggest that PANDA promotes G(1)-S transition by repressing p18 transcription, and thus promotes U2OS cell proliferation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据